Nature Biotechnology published new work on sub-zero technologies designed to reduce ice damage in organs, with the goal of extending donor-graft shelf life and giving transplant centers more time to match recipients. The report highlights technical advances aimed at preserving tissue integrity during cold storage, addressing one of the central operational constraints in organ allocation.